PTC
CRMD icon

Private Trust Company’s CorMedix CRMD Stock Holding History

Private Trust Company’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.52K Hold
449
– – ﹤0.01% 2388
2026
Q1 		$3.05K Hold
449
– – ﹤0.01% 2319
2025
Q4 		$5.22K Buy
449
+14
+3% +$155 ﹤0.01% 2154
2025
Q3 		$5.06K Buy
+435
New +$5.26K ﹤0.01% 2148

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Private Trust Company's CRMD Position: Q2 2026 in Review

Private Trust Company held its CorMedix (CRMD) position steady in Q2 2026 at 449 shares worth $3.52K. The position accounts for ﹤0.01% of the portfolio, ranked #2388.

Private Trust Company first reported a position in CRMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.22K in Q4 2025. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Private Trust Company held 449 shares of CorMedix worth $3.52K as of Q2 2026.
  • Private Trust Company left its CorMedix share count unchanged in Q2 2026.
  • CorMedix made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #2388 holding.
  • Private Trust Company first reported a position in CorMedix in Q3 2025 and has held it in 4 quarters since.
  • Private Trust Company's CorMedix position peaked at $5.22K in Q4 2025.
  • 193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.